SomaLogic SPAC merger vote heading to shareholders after SEC sign-off

BOULDER — The U.S. Securities and Exchange Commission has approved a business combination registration statement from SomaLogic Inc. and special purpose acquisition company CM Life Sciences II (Nasdaq: CMIIU), and the companies’ proposed merger — which will take SomaLogic public — will soon be voted on by CM Life Sciences shareholders. 

That shareholder meeting is set for Aug. 31, and the closure of the merger is expected immediately after an affirmative vote.

Special purpose acquisition companies, known alternatively as SPACs, are companies set up by investment groups and taken onto a public exchange with no actual business. The entities are designed…